SC
MDGL icon

SouthState Corp’s Madrigal Pharmaceuticals MDGL Stock Holding History

SouthState Corp’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05K Hold
2
– – ﹤0.01% 1038
2025
Q4 		$1.17K Hold
2
– – ﹤0.01% 1090
2025
Q3 		$918 Hold
2
– – ﹤0.01% 1086
2025
Q2 		$606 Sell
2
-2
-50% -$596 ﹤0.01% 1391
2025
Q1 		$1.32K Buy
+4
New +$1.31K ﹤0.01% 1273

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SouthState Corp's MDGL Position: Q1 2026 in Review

SouthState Corp held its Madrigal Pharmaceuticals (MDGL) position steady in Q1 2026 at 2 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #1038.

SouthState Corp first reported a position in MDGL in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.32K in Q1 2025. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

  • SouthState Corp held 2 shares of Madrigal Pharmaceuticals worth $1.05K as of Q1 2026.
  • SouthState Corp left its Madrigal Pharmaceuticals share count unchanged in Q1 2026.
  • Madrigal Pharmaceuticals made up ﹤0.01% of SouthState Corp's portfolio in Q1 2026, its #1038 holding.
  • SouthState Corp first reported a position in Madrigal Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • SouthState Corp's Madrigal Pharmaceuticals position peaked at $1.32K in Q1 2025.
  • 378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on SouthState Corp's 13F filing for Q1 2026, filed 5 May 2026.